NONSPECIFIC DYSPLASIA OF THE CONNECTIVE TISSUE – A FACTOR OF VENOUS THROMBOEMBOLIC COMPLICATIONS IN ENDOPROSTHETICS OF HIP JOINTS
Keywords:endoprosthetics, thromboembolism, endothelial dysfunction, dysplasia
Background. Important part of orthopedic surgery is endoprosthetics of hip joints, which eliminates pain syndrome, restores the amplitude of movement and the support ability of lower limbs. But some complications usually take place; venous thromboembolism is leading among them.
Objective. The aim of the study was to investigate endothelial dysfunction and activity of the hemocoagulation system at different levels of VTEC risks and thus to work out the strategy of thromboprophylaxis in patients with osteoarthrosis of the hip joint and femoral neck fracture combined with non-specific dysplasia of the connective tissue.
Methods. 219 patients of a mean age of 64.7±3.8 years old underwent surgery. In 137 (62.1%) cases, a total cement hip replacement was performed for osteoarthritis. 82 (37.4%) patients underwent total and unipolar cement hip replacement for cervical femoral neck fractures.
Results. Clinical manifestations of non-specific connective tissue dysplasia were detected in 83 (37.9%) patients that was confirmed by the laboratory determination of the level of general, bound and free oxyproline. In the postoperative period, the thrombotic process in the venous system of the inferior vena cava was diagnosed in 23 (10.5%) cases. The level of indicators of endothelium status dysfunction was much more significant in the patients in cases of nonspecific dysplasia of connective tissue. Operative intervention on the hip joint in the patients with nonspecific dysplasia of connective tissue in 11 (13.3%) cases was complicated by development of venous thrombosis. In the patients without non-specific connective tissue dysplasia, postoperative thrombosis in the system of the inferior vena cava was diagnosed in 12 (8.8%) cases.
Conclusions. Patients with osteoarthrosis of the hip joint and the femoral neck fracture accompanied by the non-specific dysplasia of the connective tissue are characterized by high levels of endothelial dysfunction and increased activity of the blood-coagulation system.
Lychagin AV, Cherepanov VG, Petrov PI, Vyazankin IA, Brkich GE. Pre-Surgery Planning of Lower Limbs Major Joints Arthroplasty. Open Access Macedonian Journal of Medical Sciences. 2019 Sep 15;7(17):2838-43.
Schünemann HJ, Cushman M, Burnett AE, Kahn SR, Beyer-Westendorf J, Spencer FA, Rezende SM, Zakai NA, Bauer KA, Dentali F, Lansing J. American Society of Hematology 2018 guidelines for management of venous thromboembolism: prophylaxis for hospitalized and nonhospitalized medical patients. Blood advances. 2018 Nov 27;2(22):3198-225.
Flevas DA, Megaloikonomos PD, Dimopoulos L, Mitsiokapa E, Koulouvaris P, Mavrogenis AF. Thromboembolism prophylaxis in orthopaedics: an update. EFORT open reviews. 2018 Apr;3(4):136-48.
Yasunaga H, Tsuchiya K, Matsuyama Y, Ohe K. High-volume surgeons in regard to reductions in operating time, blood loss, and postoperative complications for total hip arthroplasty. Journal of Orthopaedic Science. 2009 Jan 1;14(1):3-9.
Feng W, Wu K, Liu Z, Kong G, Deng Z, Chen S, Wu Y, Chen M, Liu S, Wang H. Oral direct factor Xa inhibitor versus enoxaparin for thromboprophylaxis after hip or knee arthroplasty: systemic review, traditional meta-analysis, dose–response meta-analysis and network meta-analysis. Thrombosis research. 2015 Dec 1;136(6):1133-44.
Yan X, Gu X, Xu Z, Lin H, Wu B. Cost-effectiveness of different strategies for the prevention of venous thromboembolism after Total hip replacement in China. Advances in therapy. 2017 Feb 1;34(2):466-80.
Venher I, Kostiv S, Nenashko I. Non-specific connective tissue dysplasia – a risk factor for postoperative thrombosis in the venous system of lower extremities. Health Problems of Civilization. 2016 Jan 1;10(2):51-4.
Re-Mobilize Writing Committee. Oral thrombin inhibitor dabigatran etexilate vs North American enoxaparin regimen for prevention of venous thromboembolism after knee arthroplasty surgery. The Journal of arthroplasty. 2009 Jan 1;24(1):1-9.
Liew NC, Alemany GV, Angchaisuksiri P, Bang SM, Choi G, DE DS, Hong JM, Lee L, Li YJ, Rajamoney GN, Suviraj J. Asian venous thromboembolism guidelines: updated recommendations for the prevention of venous thromboembolism. International angiology: a journal of the International Union of Angiology. 2017 Feb;36(1):1-20.
Van PY, Schreiber MA. Contemporary thromboprophylaxis of trauma patients. Current opinion in critical care. 2016 Dec 1;22(6):607-12.
Diamantouros A, Kiss A, Papastavros T, David U, Zwarenstein M, Geerts WH. The TOronto ThromboProphylaxis Patient Safety Initiative (TOPPS): A cluster randomised trial. Research in Social and Administrative Pharmacy. 2017 Sep 1;13(5):997-1003.
Zhang J, Xu J, Zhang W, Jiang M, Liu J, Xu L, Liu G, Zhao Z. Quality Appraisal of Guidelines on Cancer-Associated Thrombosis Using AGREE II Instrument and Analysis of Current Status of New Oral Anticoagulants. Clinical and Applied Thrombosis/Hemostasis. 2019 Apr 26;25:1076029619846562.
How to Cite
Authors who sent their manuscript to International Journal of Medicine and Medical Research agree to the following terms:
1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License CC-BY-NC that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
2. Authors able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).